【レポートの概要(一部)】
Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Squamous Non-Small Cell Lung Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Squamous Non-Small Cell Lung Cancer 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Squamous Non-Small Cell Lung Cancer 33
Sep 09, 2013: Oncolytics Biotech Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer 33
Aug 13, 2013: Eli Lilly and Company’s Phase III study of necitumumab meets primary endpoint 33
Jun 04, 2013: Debiopharm Announces Additional Phase I Clinical Trial Evaluating Debio 1143 Combined With Chemotherapies For Patients With Selected Solid Malignancies 33
May 23, 2013: OncoGenex Pharma Announces Plans For Initiation Of Cedar Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Squamous Cell Lung Cancer 34
Mar 28, 2013: Oncolytics Biotech Meets Primary Overall Statistical Endpoint In US Phase II Study Of Reolysin In Squamous Cell Lung Cancer 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
Novartis AG 42
Clinical Trial Overview of Novartis AG 42
GlaxoSmithKline plc 43
Clinical Trial Overview of GlaxoSmithKline plc 43
Debiopharm International S.A. 44
Clinical Trial Overview of Debiopharm International S.A. 44
Agennix AG 45
Clinical Trial Overview of Agennix AG 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Cancer Institute Hospital Japanese Foundation for Cancer Research 48
Clinical Trial Overview of Cancer Institute Hospital Japanese Foundation for Cancer Research 48
Rigshospitalet 49
Clinical Trial Overview of Rigshospitalet 49
Sarah Cannon Research Institute 50
Clinical Trial Overview of Sarah Cannon Research Institute 50
Wake Forest University 51
Clinical Trial Overview of Wake Forest University 51
Hiroshima University Hospital 52
Clinical Trial Overview of Hiroshima University Hospital 52
Eastern Cooperative Oncology Group 53
Clinical Trial Overview of Eastern Cooperative Oncology Group 53
Samsung Medical Center 54
Clinical Trial Overview of Samsung Medical Center 54
Five Key Clinical Profiles 55
Appendix 158
Abbreviations 158
Definitions 158
Research Methodology 159
Secondary Research 159
About GlobalData 160
Contact Us 160
Disclaimer 160
Source 161
【レポート販売概要】
■ タイトル:Squamous Non-Small Cell Lung Cancer:グローバル臨床試験動向(2014年上半期)■ 英文:Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月26日
■ 調査会社:GlobalData
■ 商品コード:GDHC2164CTIDB
■ 調査対象地域:グローバル
- 世界の商用航空機市場動向2013-2023:競合環境及び戦略的インサイトThe report provides a detailed analysis of the competitive landscape of the Commercial Aircraft market. It provides an overview of key Commercial Aircraft companies catering to the Commercial Aircraft sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis.
- 世界のワクチン市場パイプライン分析The global vaccine market is characterized into human and animal vaccines. The segment of human vaccines is further sub-divided into four groups namely, pediatrics, adolescents, adults and elderly. Though the vaccines segment forms a very small portion of the global pharmaceutical drug sales(2-3%), the growth rate in this market has been extraordinary. This segment has grown at a high rate of 10-1 …
- アメリカの体外診断(IVD)市場:免疫測定法、臨床化学、分子診断、微生物The U.S. is a prime market due to the availability of government funds, expansion of molecular diagnostics for genetic disorders and cancer screening, and easy access to IVD tests through diagnostic service providers and major leading companies headquartered in the U.S. The U.S. in vitro diagnostics market is estimated to reach USD 25.99 Billion by 2020, growing at a CAGR of 4.7% during the foreca …
- 世界の創傷被覆市場動向(2012-2016)TechNavio's analysts forecast the Global Wound Dressing market to grow at a CAGR of 5.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Wound Dressing market has also been witnessing the trend of increasing demand for combination dressings. However, the high cost of advanced dressing products could pos …
- ブラックスタート発電機の世界市場:ディーゼル発電機、その他The global black start generator market is expected to reach USD 1.50 Billion by 2021 at a CAGR of 3.8% from 2016 to 2021. The growth is attributed to construction of thermal, nuclear, and hydro power plants and growth of manufacturing industries across the globe. The black start generator’s prime application is in the power generation sector to provide the initial power for restarting the power p …
- 患者温度管理の世界市場分析:製品別(患者保温システム、患者冷却システム)、タイプ別(手術、循環器科、小児科、神経科)、エンドユーザー別(手術室、新生児ICU、ER、ICU)、セグメント予測、2014-2025The global patient temperature management market is anticipated to reach a value of USD 4.5 billion by 2025, according to a new report by Grand View Research, Inc. Growing number of surgical procedures is expected to have a huge impact on the demand for temperature management products. For instance, open heart surgeries require maintenance of patients’ temperature through blood cooling and, thereb …
- 世界における臨床化学および免疫診断機器市場及び主要サプライヤー動向This 68-page report reviews operating characteristics and features of high-, medium-, and low-volume/POC clinical chemistry and immunodiagnostic systems. The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new product …
- ファッションにおけるAIの世界市場予測(~2024年)Customer’s demand for a personalized experience to drive the adoption of AI in fashion across end-usersMarketsandMarkets expects the global AI in fashion market to grow from USD 228 million in 2019 to USD 1,260 million by 2024, at a Compound Annual Growth Rate (CAGR) of 40.8% during the forecast period. Major growth factors for the market include increasing need for inventory management, customer’ …
- AustraliaのArsenic市場:貿易(輸入、輸出)動向This market research report examines the foreign trade of Australia and its perspectives on the global market for arsenic. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on arsenic export/import operations in Australia. The 2002-2012 period is covered, with more emphasi …
- 静脈注射用の溶液の世界市場分析:タイプ別(全非経口栄養(TPN)、末梢非経口栄養(PPN))、栄養素(炭水化物、非経口脂質エマルジョン、単一用量アミノ酸溶液、ビタミン&ミネラル(塩および電解質))、セグメント予測The global IV solutions market was valued at USD 6.9 billion in 2015 and is expected to reach a value of USD 13.79 billion by 2024. Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition. Growing incidence rate of chronic diseases, such as cancer, is also fueling the demand for Total Parenteral Nutrition (T …
- 世界のエチレン産業動向Global Ethylene Industry - Feedstock Advantage Shifts New Investments to the US Summary GlobalData, the industry analysis specialist, has released its latest research, “Global Ethylene Industry - Feedstock Advantage Shifts New Investments to the US”. The study comes from the company’s oil and gas research group and provides market analysis of the global ethylene industry, highlighting major featur …
- デジタル・オイルフィールドの世界市場2017-2021About Digital Oilfield Market Digital oilfields refer to the application of advanced software, hardware, and data analysis techniques to increase the exploration and production efficiency of oil and gas fields. Technavio’s analysts forecast the global digital oilfield market to grow at a CAGR of 4.68% during the period 2017-2021. [Covered in this report] The report covers the present scenario and …
- バイオ潤滑油(生分解性潤滑油)の世界市場:植物油、動物油About Biolubricants The term biolubricants refers to all lubricants that are nontoxic as well as biodegradable. The rapid depletion of crude oil reserves and issues related to energy conservation and environmental protection have put an emphasis on the development of renewable, biodegradable, and environmentally friendly industrial fluids, such as biolubricants. Biolubricants have a minimum impact …
- Stone Energy Corporation:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Stone Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Stone Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- Petoro AS:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Petoro AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Petoro AS Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational dat …